Results 121 to 130 of about 3,468 (201)

Paeonol suppresses epithelial-mesenchymal transition-driven posterior capsular opacification through activation of AMPK signaling. [PDF]

Int J Ophthalmol
Wang Q, Li QY, Yang J, Ma J, Ping JH, Wang Z, Wang DJ, Hua X, Yuan XY.   +8 more
europepmc   +1 more source

Bionic design based on liposome-exosome hybrid nanoparticles for synergistic delivery of paeonol to achieve neuroprotection and improvement of motor function in Parkinson's disease model mice. [PDF]

Mater Today Bio
Wu Y, Wang C, Fang K, Zu R, Deng Y, Hu C, Cao K, Fang Y, Chen X, Liu Y, Zhang Y, Sun B, Wang L, Shen W, Xia H.   +14 more
europepmc   +1 more source

Paeonol Ameliorates Benign Prostatic Hyperplasia via Suppressing Proliferation and NF-κB-In Silico and Experimental Studies. [PDF]

Pharmaceuticals (Basel)
Lee HY, Lee MS, Lee BC.
europepmc   +1 more source

Integrative RNA-seq and LASSO-COX analysis reveal Paeonol's key target gene in proliferation suppression and apoptosis-induced in cervical cancer. [PDF]

Front Pharmacol
Li M, Gao N, Xu L, Ge P, Jiang N, Shang Y.   +5 more
europepmc   +1 more source

Anti-tumor efficacy of paeonol in endometrial cancer: a correspondence. [PDF]

Int J Surg
Xiao C, Zhang Y, Li Q.
europepmc   +1 more source

EP2-PKA signaling is suppressed by triptolide in lipopolysaccharide-induced microglia activation [PDF]

, 2015

core   +1 more source

Study of the Stability and Anti-Inflammatory Activity of Paeonol-Oleanolic Acid Liposomes by Microfluidic Technology. [PDF]

Foods
Ma X, Zhang H, Luan J, Tian M, Zhang X, Sohail A, Liang D, Liu J, Tao F, Wang Z, Wang D.   +10 more
europepmc   +1 more source

Back Matter 9 (4) [PDF]

, 1980

core   +1 more source

Editorial: Modulation of ferroptosis via metabolic and signaling pathways: therapeutic opportunities across malignancies and degenerative diseases. [PDF]

Front Pharmacol
Fiore A, Chen J, de Assis AM.
europepmc   +1 more source

Bioscience, Pathogenic Biochemistry [PDF]

, 2012
横山 悟, 櫻井 宏明, 済木 育夫
core   +1 more source